Schedule 13G ownership disclosure
RTI Biologics, Inc.
Security class unavailable · CUSIP: 74975N105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,323,070
- Percent of class
- 9.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037792-19-000008
- Form type
- SC 13G
- Filer
- PARADIGM CAPITAL MANAGEMENT INC/NY
- CIK
- CIK 1037792
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership